Lipoprotein profiles at different stages of chronic renal insufficiency

Renal Failure

Volumn 22, Issue 1, 2000, Pages 63-71

  Kimak, Elzbieta ^a   Solski, Janusz ^a   Janicka, Lucyna ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Apolipoproteins; Chronic; Different; Insufficiency; Renal; Stage

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN B; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; ATHEROSCLEROSIS; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DYSLIPOPROTEINEMIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; CREATININE; DISEASE PROGRESSION; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPOPROTEINS; MALE;

EID: 0034058825     PISSN: 0886022X     EISSN: None     Source Type: Journal    
DOI: 10.1081/JDI-100100852     Document Type: Article

References (27)

1. Appel G: Lipid abnormalities in renal disease. Kidney Int 39:169-183, 1991.
2. Attman P-O: Hyperlipoproteinemia in renal failure Pathogenesis and perspectives for intervention. Nephrol Dial Transplant 8:294-295, 1993.
3. Attman P-O, Alaupovic P: Lipid and apolipoprotein profiles of uraemic dislipoproteinemia - relation to renal function and dialysis. Nephron 57:401-410, 1991.
4. Attman P-O, Alaupovic P: Lipid abnormalities in chronic renal insufficiency. Kidney Int 39: (suppl 31). 516-523, 1991.
5. Attman P-O, Samuelsson O, Alaupovic P: Lipoprotein metabolism and renal failure. Am J Kidney Dis 21:573-592, 1993.
6. Attman P-O, Alaupovic P, Tavelle M, Knight-Gibson C: Abnormal lipid and apolipoprotein composition of major lipoprotein density classes in patients with chronic renal failure. Nephrol Dial Transplant 11:63-69, 1996.
7. Elisaf MS, Bairaktari HT, Tzialls CS, Gerinanos NK, Siamopoulos KC: Atherogenic lipid and lipoprotein parameters in hemodialysis patients. Dial Transplant 24:642-650, 1995.
8. Siamopoulos GI, Elisaf MS. Bairaktari HT, Papes MB, Sferopoulos GI. Nikolakakis NG: Lipid parameters including lipoprotein(a) in patients undergoing CAPD and hemodialysis. Perit Dial Int 15:342-347, 1995.
9. Dairou F: Lipid disorders and cardiovascular risks in nephrology. Nepbrol Dial Transplant 13 (Suppl 4):30-33, 1998.
10. Lacour B, Roulet JM, Beyne P, Kreis H, Thevenin M, Drüeke T: Comparison of several atherogenicity induces by the analysis of serum lipoprotein composition in patients with chronic renal failure with or without hemodialysis, and in renal transplant patients. J Clin Chem Clin Biochem 23:805-810, 1985.
11. Attman P-O, Samuelsson O, Alaupovic P: Progression of renal failure: role of apo B-containing lipoproteins. Kidney Int 52 (Suppl 63):98-101, 1997.
12. Attman P-O: Progression of renal failure and lipids is there evidence for a link in humans? Nephrol Dial Transplant 13:545-547, 1998.
13. Samuelsson O, Aurell M, Knight-Gibson C, Alaupovic P, Attman P-O: Apolipoprotein-B-contaimng lipoproteins and the progression of renal insufficiency. Nephron 63:279-285, 1993.
14. Samuelsson O, Attman P-O, Knight-Gibson C, Kron B, Larsson R, Mulec H, Weiss L, Alaupovic P: Lipoprotein abnormalities without hyperlipidemia in moderate renal insufficiency. Nephrol Dial Transplant 9:1580-1586, 1994.
15. Samuelsson O, Mulec H, Knight-Gibson C, Attman P-O, Kron B, Larsson R, Weis L, Wedal H, Alaupovic P: Lipoprotein abnormalities are associated with increased rate of progression of human chronic renal insufficiency. Nephrol Dial Transplant 12: 1908-1915, 1997.
16. Keane WF, O'Donnell MP, Kasiske BL, Schmitz PG: Lipids and the progression of renal disease. J Am Soc Nephrol 1:5690-5704, 1990.
17. Burton C, Harris KPG: The role of proteinuria in the progression of chronic renal failure. Am J Kidney Dis 27: 765-775, 1996.
18. Moorhead JF, Chan MK, El Nahas M, Varghese Z: Lipid nephrotoxicity in chronic progressive glomerular and tubulointerstitial disease. Lancet 1:1309-1311, 1982.
19. Kimak E, Solski J, Janicka L, Duma D, Zagojska M: Plasma lipoprotein in patients with chronic renal failure (CRF). Int Urol Nephrol 29:597-601, 1997.
20. Kimak E, Solski J, Janicka L, Zagojska M: Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency. Int Urol Nephrol 1997; in press.
21. ONeal D, Lee P, Murphy B, Best J: Low-density lipoprotein particle size distribution in end-stage renal disease treated with hemodialysis or peritoneal dialysis. Am J Kidney Dis 27:84-91, 1996.
22. Keane WF: Lipids and the kidney. Kidney Int 46:910-920, 1994.
23. Krämer-Guth A, Nauck M, Pravenstadt H et al.: Preferential uptake of intermediate density lipoproteins from nephrotic patients by human mesangial and liver cells. J Am Soc Nephrol 5:1081-1090, 1994.
24. Takemura T. Yoshioka K, Aya N et al.: Apolipoprotein receptors in glomeruli in human kidney diseases. Kidney Int 43:918-927, 1993.
25. Oda H, Keane WF: Lipid abnormalities in end stage renal disease. Nephrol Dial Transpl 13 (Suppl 1):45-49, 1998.
26. Sakurai T, Oka T, Hasegawa H, et al.: Comparison of lipids, apolipoproteins and associated enzyme activities between diabetic and non diabetic end-stage renal disease. Nephron 61:409-414, 1992.
27. Kamanna VS, Kashyap ML, Pai R, et al.: Uremic serum subfraction inhibits apolipoprotein A1 production by a human hepatoma cell line. J Am Soc Nephrol 5:193-200, 1994.